Turkish Journal of Gastroenterology
Pediatric Gastroenterology - Original Article

A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy

1.

Department of Pediatric Gastroenterology, Başkent University Hospital, Ankara, Turkey

2.

Department of Pediatric Gastroenterology, Başkent University Faculty of Medicine, Ankara, Turkey

3.

Department of Pediatric Allergy, Başkent University Hospital, Ankara, Turkey

4.

Department of Pathology, Başkent University Hospital, Ankara, Turkey

5.

Department of Pediatric Oncology, Başkent University Hospital, Ankara, Turkey

6.

Department of General Surgery and Transplant Surgery, Başkent University Hospital, Ankara, Turkey

Turk J Gastroenterol 2018; 29: 354-360
DOI: 10.5152/tjg.2018.17731
Read: 718 Downloads: 139 Published: 25 July 2019

Abstract

Background/Aims: We evaluated our 16-year single-center experience of pediatric post-transplant lymphoproliferative disorder (PTLD) cases who underwent liver transplantation between 2001 and 2017. 

Materials and Methods: Of the 236 pediatric patients who underwent liver transplantation between 2001 and 2017, the clinical and laboratory data of eight patients diagnosed with PTLD were reviewed. The pre-transplant Epstein-Barr virus (EBV) status of 172 patients was also recorded.

Results: The total incidence of PTLD was 3.4%. The incidence of PTLD was 10% in pre-transplant EBV immunoglobulin G (IgG)-seronegative patients and 0.8% in pre-transplant EBV IgG-seropositive patients. The mean age of the patients at liver transplantation was 2.71±3.21 years, and four patients were aged below 1 year at the time of transplantation. PTLD was diagnosed at 21.81±18.1 months after transplantation. The primary site of involvement was variable among patients: peripheral and mediastinal lymph nodes, stomach and intestine, transplanted graft, bone marrow, and nasopharynx. The eosinophil count varied greatly among patients, with a mean value of 524.62±679/mm3. Three patients had a food allergy and were administered an elimination diet at the time of PTLD diagnosis. Six patients had PTLD of B-cell origin. One patient died due to neutropenic sepsis during chemotherapy, whereas seven patients were followed up in full remission for 7.75±4 years.

Conclusion: PTLD is a life-threatening complication of solid-organ transplantation with a heterogeneous clinical spectrum. Food allergy had a close association with PTLD. A close follow-up of patients with risk factors and an early diagnosis with appropriate treatment may lead to a better outcome.

Cite this article as: Barış Z, Özçay F, Yılmaz Özbek Ö, Haberal N, Sarıalioğlu F, Haberal M. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: Incidence, outcomes, and association with food allergy. Turk J Gastroenterol 2018; 29: 354-60.

 

Files
EISSN 2148-5607